Page 34 - Michael Erman News Today

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm

The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Incs $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal. ... | June 12, 2023

Pfizer Chief Executive Albert Bourla called US plans to negotiate drug prices for its Medicare health program negotiation with a gun to your head.

By Michael Erman and Bhanvi Satija

Pfizer Inc is pouring the windfall profits from its COVID-19 vaccine and treatment into developing products to battle cancer, most notably in its $43 billion purchase of Seagen Inc, Chief...

Pfizer Inc Chief Executive Albert Bourla on Thursday called U.S. plans to negotiate drug prices for its Medicare health program negotiation with a gun to your head and said he expects drugmakers to... | May 11, 2023

Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program negotiation with a gun to your head and said he expects drugmakers to sue in... | May 11, 2023

By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug prices for its Medicare ...

By Michael Erman (Reuters) - Pfizer Inc is pouring the windfall profits from its COVID-19 vaccine and treatment into developing products to battle can...